In retrospective studies, tumors with more normalized vascular architecture (e.g., organized, more linear patterns) have been associated with more favorable outcomes to some standard therapies (e.g., immune checkpoint inhibitors). By contrast, tumors with more complex vascular architecture (e.g., twisted, disorganized patterns) have been associated with less favorable outcomes and lower responsiveness in some settings.